This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

TiVo: Small-Cap Winner

NEW YORK ( TheStreet) -- Shares of TiVo (TIVO - Get Report) jumped 38% to $11.54 Wednesday, with volumes topping 30 million shares in noon trading.

The U.S. Court of Appeals upheld a district court's ruling of contempt against EchoStar Communications in an ongoing patent dispute between the two companies. TiVo is seeking a permanent injunction against EchoStar and Dish Network for infringing on a TiVo patent.

Puerto Rico-based bank Doral (DRL - Get Report) saw its shares soar 32% to $1.37 after it reported a net profit of $3.3 million, reversing a $3.5 million loss in the year ago quarter on the back of improving asset quality.

Shares of Prana Biotech (PRAN) were gaining 16% to $2.58 after the company said it was accelerating the development of its PBT2 compound that is used to treat Alzheimer's Disease and Huntington's Disease.

Shares of bio-pharma company Oxigene (OXGN) were gaining 7% to $1.73. The company announced that clinical investigators have enrolled the first patient in phase 2 trials of of Zyberstat in patients with ovarian cancer.

AEZS Pharmaceuticals (AEZS - Get Report) and ACADIA Pharmaceuticals (ACAD - Get Report) were other biotech stocks in play on Tuesday, rising 5% and 4.6% respectively.

Shares of Jaguar Mining (JAG - Get Report) surged 5.6% to $5.77 after JPMorgan upgraded its rating on the gold miner to an overweight from neutral.

--Written by Shanthi Bharatwaj in New York



>To contact the writer of this article, click here: Shanthi Bharatwaj.

>To follow the writer on Twitter, go to http://twitter.com/shavenk.

>To submit a news tip, send an email to: tips@thestreet.com.

Disclosure: TheStreet's editorial policy prohibits staff editors and reporters from holding positions in any individual stocks.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
JAG $0.00 0.00%
ACAD $40.10 -1.11%
AEZS $0.30 -1.99%
DRL $0.08 6.67%
PRAN $1.28 -3.76%

Markets

DOW 18,041.54 -190.48 -1.04%
S&P 500 2,104.20 -21.86 -1.03%
NASDAQ 5,032.7510 -56.6110 -1.11%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs